Draft Compliance Policy Guidance for FDA Employees and Industry on Blood Donor Incentives; Availability

Özet

The Food and Drug Administration (FDA) is announcing the availability of the draft compliance policy guidance entitled "Sec. 230.150 Blood Donor Incentives." The draft guidance is intended to provide guidance to FDA employees and industry for evaluating blood donor incentives that may consist of cash or other incentives.